作为抗癌治疗的新目标的补充调节剂:综合性审查
Ruchi Saxena1, Elizabeth B Gottlin2, Michael J Campa2
1Department of Integrative Immunobiology, Duke University School of Medicine, Durham, NC 27710, USA.
Seminars in immunology
|January 18, 2025
概括
补体系统是天生的免疫系统的一部分,在癌症中起着双重作用. 研究人员正在探索补充调节器作为新型抗癌疗法的潜在目标.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 癌症治疗寻求先进的,个性化疗法超越手术,化疗和放射治疗.
- 免疫疗法已经成为一项有前途的癌症治疗策略.
- 补体系统是先天免疫的关键组成部分,因其在癌症中的复杂作用而越来越被认可.
研究的目的:
- 审查补充调节器在癌症发展和进展中的复杂作用.
- 检查补充调节器作为癌症的潜在治疗点.
- 讨论当前的策略,挑战和临床研究,以准癌症治疗的补充调节剂.
主要方法:
- 科学文章和临床研究的文献评论.
- 分析补充系统在癌症生物学中的双重作用.
- 检查瘤微环境中的特定补充调节剂 (CD46,CD55,CD59,补充因子H).
主要成果:
- 补体系统具有取决于环境的作用,可能有助于免疫监测或促进瘤进展.
- 补充调节剂 (CD46,CD55,CD59,补充因子H) 与瘤微环境有关.
- 这些监管机构为新的抗癌策略提供了潜在的治疗点.
结论:
- 补充监管机构代表了开发向癌症治疗的有前途领域.
- 需要进一步的研究和临床试验才能充分实现向癌症补充系统的治疗潜力.
- 了解补充调节器和癌症之间的复杂相互作用对于推进治疗选择至关重要.
相关概念视频
01:45Positive Regulator Molecules
105.7K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
105.7K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
468
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
468
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
01:15Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K